PLYMOUTH MEETING, Pa. Surveillance Data, Inc. is more and more becoming a turnkey data solution center, providing marketable intelligence around specific disease states that can be employed both behind the bench and across the front-end, Scott Hanslip, SDI VP global sales, told Drug Store News during the ECRM Cough-Cold & Allergy conference held earlier this month in Jacksonville, Fla.
In other words, SDI isn’t just your source for FAN data anymore. (The Flu/Cold/Respiratory Activity Notification program measures the total affected population with upper respiratory illness at the national level down to 135 markets, according to SDI.)
SDI is the leading provider of HIPPA-compliant, de-identified patient-level data analytics, and with that, provides a broad array of solutions and insights across the continuum of care. SDI is able to overlay expanded consumer demographics and lifestyle behavior data.
For example, SDI can narrow the prevalence of a specific disease state — such as heart disease — geographically within a three-digit zip code. As a targeting tool alone, that intelligence can help retailers and suppliers either hone their offerings addressing that specific disease state or conduct comprehensive test-marketing to validate a merchandising or marketing program, Hanslip said.